Skip to main navigation

Skip to content

Side Menu

About Us
Our Platform
Our Programs
Patients and Physicians
Inside Seres
Open Positions
Investors and News
Contact Us

Press Releases

Seres' news, events and other information can be found throughout the pages below.

Investor Relations

Stock Information
News and Events
- Press Releases
- Events & Presentations
Financial Information
- SEC Filings
- Annual Reports
Corporate Governance
Shareholder Services

Press Releases

Keyword Search

Year

Mar 12, 2021

Seres Therapeutics to Present at the 31st Annual Oppenheimer Healthcare Conference

Mar 08, 2021

Seres Therapeutics Announces Discontinuation of Enrollment in SER-401 Study in Metastatic Melanoma

Mar 02, 2021

Seres Therapeutics Announces Achievement of Target Enrollment in SER-287 Phase 2b ECO-RESET Study for Ulcerative Colitis

Mar 02, 2021

Seres Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Updates

Feb 26, 2021

Seres Therapeutics to Participate in Upcoming Virtual Investor Conferences

Feb 24, 2021

Seres Therapeutics to Host Fourth Quarter 2020 Financial Results and Operational Progress Conference Call on March 2, 2021

Jan 19, 2021

Seres Therapeutics to Present SER-109 Phase 3 Mechanistic Data at Keystone Symposium

Jan 06, 2021

Seres Therapeutics Publishes Positive SER-287 Phase 1b Ulcerative Colitis Study Results in Journal Gastroenterology

Jan 06, 2021

Seres Therapeutics to Present at 39th Annual J.P. Morgan Healthcare Conference

Shareholder Tools

RSS Feeds
E-mail Alerts
Print

© 2021 Seres Therapeutics.

Footer Left Menu

Privacy Policy
Terms of Use

Follow us on Linkedin
Follow us on Twitter
Follow us on Facebook